Literature DB >> 9443684

Ludwig symposium on biliary disorders--part I. Pathogenesis of ductal plate abnormalities.

V J Desmet1.   

Abstract

Intrahepatic bile ducts (IHBDs) develop from bipotential liver progenitor cells in contact with the mesenchyme of the portal vein and thus form the "ductal plates." The ductal plates are remodeled into mature tubular ducts. Lack of remodeling results in the persistence of periportal epithelial sleeves or "ductal plate malformation" (DPM). A proposal is that virtually all congenital diseases of IHBDs represent examples of DPM. Some early, severe types of extrahepatic bile duct atresia are characterized by DPM, a suggestion of a prenatal beginning of the disease. Several congenital diseases are characterized by dilatation of segments of IHBDs and variable degrees of fibrosis. Such "fibrocystic diseases" represent DPM at different levels of the biliary tree. Autosomal recessive polycystic kidney disease represents DPM of interlobular bile ducts, associated with tubular dilatation of collecting renal tubules. Congenital hepatic fibrosis may derive from the same type of liver lesion, through a superimposed destructive type of cholangiopathy associated with scarring fibrosis. Caroli's disease represents DPM of the larger IHBDs, whereas Caroli's syndrome combines the lesions of Caroli's disease and congenital hepatic fibrosis. von Meyenburg complexes represent DPM of smaller interlobular ducts; their dilatation gives rise to the liver cysts in autosomal dominant polycystic kidney disease. Finally, DPM is a component of the tissue abnormalities in so-called mesenchymal hamartoma.

Entities:  

Mesh:

Year:  1998        PMID: 9443684     DOI: 10.4065/73.1.80

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  65 in total

1.  Multiple bile duct hamartomas mimicking diffuse hepatic metastasis: GI image.

Authors:  Ashish Singhal; Rajesh Kanagala; Harlan I Wright; Vivek Kohli
Journal:  J Gastrointest Surg       Date:  2010-05-18       Impact factor: 3.452

2.  Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: summary statement of a first National Institutes of Health/Office of Rare Diseases conference.

Authors:  Meral Gunay-Aygun; Ellis D Avner; Robert L Bacallao; Peter L Choyke; Joseph T Flynn; Gregory G Germino; Lisa Guay-Woodford; Peter Harris; Theo Heller; Julie Ingelfinger; Frederick Kaskel; Robert Kleta; Nicholas F LaRusso; Parvathi Mohan; Gregory J Pazour; Benjamin L Shneider; Vicente E Torres; Patricia Wilson; Colleen Zak; Jing Zhou; William A Gahl
Journal:  J Pediatr       Date:  2006-08       Impact factor: 4.406

Review 3.  The immunopathology of human biliary cell epithelium.

Authors:  Ya-Hui Chuang; Ruth Y Lan; M Eric Gershwin
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

Review 4.  Liver and kidney disease in ciliopathies.

Authors:  Meral Gunay-Aygun
Journal:  Am J Med Genet C Semin Med Genet       Date:  2009-11-15       Impact factor: 3.908

5.  Isolated polycystic liver disease and aneurism: a case report.

Authors:  Nikolaos Fassiadis; Sofia Lampaki; Paul Zarogoulidis; Drosos Tsavlis; Theodora Tsiouda; Ioanna Kougioumtzi; Nikolaos Machairiotis; Pavlos Pavlidis; Charalampos Charalampidis; Kosmas Tsakiridis
Journal:  Ann Transl Med       Date:  2016-05

Review 6.  Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases.

Authors:  Bassam Abu-Wasel; Caolan Walsh; Valerie Keough; Michele Molinari
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

7.  Caroli's disease: report of surgical options and long-term outcome of patients treated in Argentina. Multicenter study.

Authors:  Javier C Lendoire; Gabriel Raffin; Jorge Grondona; Ricardo Bracco; Rodolfo Russi; Victoria Ardiles; Gabriel Gondolesi; Jorge Defelitto; Eduardo de Santibañes; Oscar Imventarza
Journal:  J Gastrointest Surg       Date:  2011-07-28       Impact factor: 3.452

8.  Tregs: A Therapeutic Target for the Treatment of Portal Fibrosis?

Authors:  Yuhua Xue; George Michalopoulos
Journal:  Dig Dis Sci       Date:  2015-05-14       Impact factor: 3.199

9.  MicroRNAs in Cholangiopathies.

Authors:  Steven P O'Hara; Sergio A Gradilone; Tetyana V Masyuk; James H Tabibian; Nicholas F LaRusso
Journal:  Curr Pathobiol Rep       Date:  2014-09-01

10.  Bile duct cyst type V (Caroli's disease): surgical strategy and results.

Authors:  Javier Lendoire; Pablo Barros Schelotto; Juan Alvarez Rodríguez; Fernando Duek; Carlos Quarin; Verónica Garay; Marcelo Amante; Eduardo Cassini; Oscar Imventarza
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.